Enzymatica AB (publ) (STO:ENZY)

Market Cap	463.62M
Revenue (ttm)	52.73M
Net Income (ttm)	-54.14M
Shares Out	242.74M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,706
Average Volume	130,411
Open	2.000
Previous Close	1.910
Day's Range	1.855 - 2.000
52-Week Range	1.340 - 5.450
Beta	0.30
RSI	46.56
Earnings Date	Feb 18, 2026

About Enzymatica AB

Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 21
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ENZY

Financial Performance

In 2024, Enzymatica AB's revenue was 45.58 million, a decrease of -10.47% compared to the previous year's 50.90 million. Losses were -53.18 million, 6.94% more than in 2023.